Plain-English translation of NCT07755410 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help adults with attention-deficit hyperactivity disorder (ADHD) manage their symptoms better than a placebo. Researchers want to understand whether the medication is safe and actually works for people struggling with focus, attention, or impulsivity. About 312 adults will participate, with some receiving the new treatment at different dose levels and others receiving a placebo to compare results.
While treatments for ADHD already exist, researchers are constantly looking for new options that may work better or with fewer side effects for adults who struggle with attention and focus. This trial tests whether this new medication could be a helpful addition to the current treatment options available.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will be randomly assigned to take either the new medication at one of three different doses or a placebo pill, all taken daily. You will attend visits where doctors will check your health, ask how you're feeling, and measure whether your ADHD symptoms have improved. The study compares your progress on the medication to those taking placebo to determine if the treatment really works.
AI-generated summary from trial data ยท Aug 13, 2026 ยท Not medical advice
United States